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Abstract: DNA ploidy measurement has been applied uniquely to wax-embedded tissue of 
primary renal cell and metastatic tumours of a key experimental researcher on porcine 
ochratoxicosis, a control, and four transitional cell carcinomas from cases of Balkan 
endemic nephropathy. Primary renal tumour was diploid, and hyperdiploid metastasis was 
within the lower ploidy range for typical renal cell carcinoma. Three Balkan primary 
tumours showed extensive aneuploidy indicating marked nuclear instability, similar to 
model rat renal carcinoma caused by ochratoxin A. In contrast, much less nuclear instability 
in the putative occupational ochratoxicosis case fitted poorly with the ochratoxin A model. 
Keywords: DNA ploidy; Balkan endemic nephropathy; renal cell carcinoma; ochratoxin 
A; porcine nephropathy; metastasis; nuclear instability; transitional cell carcinoma; 
aneuploidisation 
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1. Introduction 
The study arises from the potent nephrocarcinogenicity of the mycotoxin ochratoxin A (OTA), the 
fact that most human renal tumours are idiopathic, and the uncertain designation of dietary OTA as a 
human health risk. 
Ochratoxin A is one of the first–discovered mycotoxins. Recognised in South Africa as a fungal 
metabolite that was toxic to experimental rats [1], the structure was also determined there [2]. OTA 
became more widely important in the 1970s when implicated in the aetiology of the chronic porcine 
nephropathy that was occurring sporadically in Danish pigs [3,4]. OTA occurrence in Denmark was 
associated particularly with mould spoilage of home-grown cereals destined for pig feed that had not 
been dried adequately before storage. 
A curious human nephropathy was recognised as a discrete entity in the Vratza district of Bulgaria 
in the mid-1950s [5,6] and gradually became recognised more widely within the Balkans as an 
idiopathic nosologic entity of mosaic occurrence in certain households in certain agricultural villages. 
It manifests as a silent progressive bilateral renal atrophy that generally becomes apparent in late 
middle age. The pathology was addressed formally by the World Health Organisation [7], was a topic 
for a CIBA Foundation Study [8], and articles on it gradually appeared in Western European literature, 
summarised in [9]. Concurrently, there was a climate of expanding discovery of fungal metabolites 
(e.g., aflatoxin B1, zearalenone and several trichothecenes) as potent agents of natural mammalian 
disease. Since Danish veterinarian Professor Palle Krogh had been much involved in large-scale pig 
experiments on OTA and renal disease, it was just imaginative lateral-thinking for him to propose that 
the mycotoxin might also be an agent of human disease, particularly the Balkan endemic nephropathy [10]. 
Balkan endemic nephropathy (BEN) occurred mainly in flood-plain regions associated with the 
Danube and its tributaries, but was focused on particular households, irrespective of ethnic origin,  
in rural communities in which storage conditions for agricultural commodities, predominantly   
home-grown for humans and for pigs, were susceptible to mould spoilage. Thus causal association 
with Danish porcine nephropathy was readily made [3] following detection of OTA in cereals [11] and 
experimental studies based on the natural occurrence of OTA in Danish cereals [12]. Consequently, 
research was stimulated within and outside Balkan countries into the human disease, the extent and 
identity of endemic mould sources of OTA, the incidence of the toxin in human diet, and on assessing 
the potential human risk of traces of OTA in human food. 
Whereas, in its original South African discovery, OTA was a metabolite of an isolate of   
Aspergillus ochraceus, which is not a part of the natural mycobiota in Northern European latitudes 
(where Penicillium verrucosum was the producing fungus), it was not easy to predict the source in the 
Balkans, where climate is more temperate although winters can be cold.  
Studies on moulds contaminating foodstuffs from nephropathy households in hyperendemic villages 
in Croatia and Bulgaria revealed no evidence of ochratoxinogenic P. verrucosum; A. ochraceus was 
very rare and usually was not ochratoxinogenic in laboratory culture on cereal substrate [13,14]. 
Concurrently, A. ochraceus was isolated from 10% of 855 samples of stored cereals and dried meats 
collected (1980–1987) from nephropathy and non-nephropathy households in Croatia [15]. One third 
of isolates were slightly ochratoxinogenic in laboratory culture but only one, from ham, was a 
prominent producer with yield similar to a reference culture. It was concluded that there was no Toxins 2010, 2               
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significant difference in ochratoxinogenic mycobiota between the two regions. Otherwise, the only 
other systematic mycological study was on 14 samples of poor quality wheat tailings used in feed of 
pigs expressing typical clinical symptoms of mycotoxic porcine nephropathy in Bulgaria [16];   
A. ochraceus was a rare component in only four of these but was not ochratoxinogenic in   
laboratory culture. 
The problem of mycotoxic porcine nephropathy in Denmark became less prevalent as moisture in 
grain for storage became controlled more rigorously. Consequently, concern over OTA waned 
somewhat until results of a US National Toxicology Programme (NTP) study on the toxicology of 
OTA appeared [17], showing it to be the most potent rat renal carcinogen found to date. This 
distinction still prevails [18]. Additionally, the incidence of upper urinary tract tumours amongst 
subjects diagnosed with the Balkan nephropathy was found to be up to 100-fold higher than amongst 
Balkan populations not affected by the bilateral renal atrophy [19]. Naturally, concern then became 
heightened regarding a putative added aetiological connection between OTA and human urological 
tumours, most of which were, and still are, of uncertain/unknown cause. 
Shortly before the NTP study was published, Palle Krogh was diagnosed with a renal cell 
carcinoma (RCC) requiring radical nephrectomy in 1988, but tragically he died 2 years later. This 
might ironically have been a unique case of potential occupational accidental exposure to the potent 
OTA during his practical involvement in large-scale pig experiments before its carcinogenic potential 
had been fully realised. To our knowledge, no person who has died from renal cell carcinoma has also 
been shown specifically to have been exposed to abnormal amounts of OTA. Trace amounts (~1 ppb) 
of OTA are found widely in human blood but no human morbidity has yet been attributed conclusively 
to OTA. 
Recently, the opportunity arose to measure DNA ploidy distribution in experimental rat renal 
tumours that had occurred in response to dietary OTA during lifetime studies [20 and associated 
experiments]. Differentiation of tumours into adenomas and carcinomas by histopathological criteria 
was consistently correlated with diploid and markedly aneuploid status, respectively [21]. That study 
has now been extended to include some archived human pathological material, particularly including 
primary renal tumour and a distant metastatic tumour of Palle Krogh, and a control renal tumour for 
which abnormal OTA exposure was not suspected. The technique has been extended into a pilot study 
of four archived upper urinary tract transitional cell carcinomas (TCC) from cases of Balkan endemic 
nephropathy to test its efficacy and contribute to current debate on the validity of extrapolation from 
animal experiments with OTA to human risk. The pilot study also assessed potential for meaningful 
application of DNA ploidy measurement to the extensive histological archives of TCC from Balkan 
nephropathy cases, as well as to currently-emerging cases.  
2. Results 
DNA ploidy distribution in Palle Krogh’s RCC, and in the control RCC, was diploid in both regions 
analysed (Figure 1 A, B). DNA in nuclei of a distant metastasis had an aneuploid distribution, with one 
main hyperdiploid peak and only occasional nuclei of higher ploidy (Figure 1D). The primary clear 
cell tumour (Figure 3B) had extended into the renal vein; this tissue also had a diploid distribution 
pattern (Figure 1C) matching the mass of tumour at the renal pole. However, a histological preparation Toxins 2010, 2               
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of a serial section adjacent to those taken for ploidy analysis revealed occasional pleomorphic nuclei 
(Figure 2) near to the venous lumen. Whereas their ploidy status is unknown, it is possible that 
aneuploidisation had already commenced in this part of the primary tumour, from which metastatic 
dissemination might readily have occurred.  
Figure 1. DNA ploidy distribution graphs for nuclei of tumour tissues. A; typical diploid 
display for the UK renal cell carcinoma (RCC) providing ‘control’ data for that of three 
Krogh tumour tissues. B; main mass of Krogh RCC (diploid), C; Krogh tumour extending 
into renal vein (diploid), D; Krogh distant aneuploid metastasis (hyperdiploid). Ploidy 
chart nuclear codes: black = renal epithelial cells, white = internal control lymphocytes, 
shaded = internal control fibroblasts. 
 
Figure 2. H & E stained histopathology of RCC extending into the renal vein, showing 
occasional pleomorphic nuclei. 
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Figure 3. H & E stained histopathology of RCC. Left; UK ‘control’ tissue. Right above; 
Krogh’s typical clear cell renal tumour. Right below; disorganised aneuploid tissue of the 
distant metastasis. Synchronised magnification from a ×20 objective. 
 
 
DNA ploidy in one of the Balkan TCC was diploid (Figure 4C; case 3), as was the skin tumour 
control (Figure 4C). However, the other three TCC were markedly aneuploid (Figure 4A, B, D;   
cases 1, 2, 4) although none of these distributions contained a significant hyperdiploid component. 
Case 1 aneuploidy was mainly hypertriploid, but in cases 2 and 4 aneuploidy extended considerably 
beyond tetraploid. The factors of tumour size and grading and association with pyelonephritis in the 4 
tumours did not correlate with the degree of aneuploidisation. There was also considerable variation in 
the histopathology among the four Balkan TCC (Figure 4A–D). 
3. Discussion 
3.1. The renal cancer cases 
The Krogh case study focuses on RCC developing silently in a Caucasian male in a developed 
Western European environment during middle age. The morbidity provoking surgical intervention 
occurred only when the primary tumour had already become rather large. However, although archived 
renal tumour had a diploid DNA distribution in the analysed tissue, subsequent survival for only two 
years after radical nephrectomy pointed to some further clonal selection for metastasis, prior to 
nephrectomy, as evidenced by the aneuploidy of a metastatic carcinoma discovered subsequently. 
Unfortunately, metastatic tissue from lung at the terminal stage had not been archived. However, it is Toxins 2010, 2               
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tantalising to contemplate whether occasional nuclear instability in tumour invading the renal vein had 
already been a crucial step spawning aggressive metastasis to distant organs. 
Figure 4. Matched DNA ploidy distribution and H & E stained histopathology of four 
Romanian transitional cell  carcinomas (TCC) from upper urinary tract of subjects 
diagnosed with BEN. A, B and D: aneuploid tumours of cases 1, 2 and 4, respectively.  
C: Typical diploid data of a ‘control’ tumour from skin, adjacent to a similar pattern in a 
diploid TCC with matching histopathology (case 3). Notably, a hyperdiploid population of 
nuclei, as in the Krogh distant metastasis, is absent in all cases. Magnifications: A,D x 400 
; B,C x 200. Ploidy chart nuclear codes: green = renal epithelial cells, red = internal control 
lymphocytes, blue= internal control fibroblasts. 
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Figure 4. Cont. 
 
 
 
The picture fits closely into the current pattern exhibited by West European cases of RCC as shown 
in a recent publication on clinical and molecular aspects of the disease [25]. The case also conforms to 
recent surveys of DNA ploidy distribution in RCC cases coming to radical nephrectomy, with 
aneuploidisation discovered in some part of the primary tumour correlating with tumour classification, 
so that a switch from diploidy to aneuploidy is a feature developing late within a RCC [26,27]. 
Specifically, the significant hyperdiploid component in the Krogh metastatic tumour corresponds to the 
ploidy distribution illustrated as within the typical range for clear cell RCC [27]. The present ploidy 
analysis of both primary tumour and distant metastasis is possibly the first individual sequence 
reported for human RCC. For human renal tumours, ploidy analysis of up to five regions of the tissue 
is desirable for a reliable measure, but in many of the rat renal tumours attributed to OTA [21] analysis 
was made on all, or a large proportion of, the tumour. Pinto et al. [25] stated ‘patients presenting Toxins 2010, 2               
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aneuploid tumours are estimated to be 15.6 times more likely to die of the disease than are those with 
diploid tumours’. The clear sequence from diploid primary tumour to aneuploid secondary tumour in 
the Krogh case is illustrative of the aneuploidisation principle, and it is tantalising to consider whether 
renal vein invasion had been involved in this process. In retrospect, a stage of T4N0M1 could be 
ascribed to the primary renal tumour, consistent with a poor actual outcome and particularly on 
account also of the venous invasion [28]. 
The mechanisms of initiation and proliferation of human RCC remain generally obscure. Some 
predisposing factors such as analgesic abuse (notably phenacetin) are recognised, but otherwise the 
disease seems just to be linked non-specifically to societies with an affluent lifestyle [29]. That specific 
DNA damage is necessary for the initial adenoma lesion, and again for differentiation into 
metastasising carcinoma, has justified study of the rare familial form of RCC, involving homozygous 
occurrence of the von Hippel Lindau recessive gene mutation, as an interesting putative model. 
However, study of early stages of human RCC is extremely difficult. Hence in the Krogh case, the 
close professional involvement in experimental ochratoxicosis A in farm and laboratory animals at a 
time when the possible human risk, as then perceived, could not have been fully appreciated, might 
have allowed unwise and un-natural exposure to the toxin. The pathological outcome might therefore 
be a pointer to OTA as a human carcinogen. For this reason, in the absence of any human cases in 
which OTA has been shown to cause any morbidity, several putative mechanisms have been proposed 
to account for carcinogenesis in the specific renal tumours that have been produced experimentally in 
male rats by OTA [30–33]. The relative contribution of these remains unclear while official 
uncertainty about the genotoxicity of OTA as a chemical carcinogen persists [34].  
However, the present finding of rather limited aneuploidisation (hyperdiploid) only in the Krogh 
metastatic tumour does not fit comfortably with the marked nuclear instability implied from the 
extreme aneuploidy (up to ~32-ploid) in primary rat renal carcinomas caused by OTA [21] and the 
case can not provide evidence supporting the IARC classification of OTA as a potential human 
carcinogen [35]. In contrast, the extreme aneuploidy found in the TCC of most of the Romanian BEN 
patients, matches that found in rat OTA tumours [21] quite closely. Human tumours initially develop 
with minimal genetic damage, as revealed by the DNA ploidy measurement, but only develop nuclear 
instability at the stage at which they metastasise. OTA tumours in rats develop marked nuclear 
instability quite early, often in situ and certainly before metastasis, and develop multiple aneuploid 
stem lines and aneuploid cells early during proliferation of the mass. The Krogh RCC showed no 
evidence of this until metastasis and thus this human type is unlikely to be due to OTA. Wider study of 
nuclear instability in TCC of BEN patients from across the Balkans would assist in consolidating the 
apparent contrasting situation in RCC and TCC. The technique used here is particularly designed to 
enable measurements on wax-embedded archival tissue.  
3.2. Balkan endemic nephropathy: The ochratoxin A hypothesis  
The aetiology of the insidious bilateral renal atrophy of BEN, and the TCC with which it is 
frequently associated, remains at most uncertain, as is also the extent to which the two disparate 
pathologies of atrophy and proliferation have a common cause. Krogh’s perception of OTA’s 
involvement concerned just the very slow human nephropathy, but was based on general extrapolation Toxins 2010, 2               
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from the relatively more rapid Danish mycotoxic nephropathy in bacon pig production. However, there 
has always been the uncomfortable juxtaposition of the marked renal hypertrophy in pigs (also 
associated with impaired live-weight gain) with the progressive silent renal atrophy in BEN, which are 
not easy to reconcile through a common pathological mechanism [36]. A more plausible role for OTA 
might concern the TCC in BEN patients, because of a presumed greater availability of unmetabolised 
OTA passing through partially dysfunctional fibrotic kidney and thus having access to the transitional 
cell epithelia of the renal pelvis and ureter. Increased OTA concentration has also been detected in sera 
of BEN patients from Croatia, compared to controls [37], supporting the idea of a dysfunctional kidney 
unable to clear the mycotoxin efficiently from the body. Moreover, the principal DNA adduct 
attributed to covalent binding with OTA was detected in three Balkan renal pelvis tumours, but also in 
bladder tumours [38,39]. However, it is important to know whether evidence of genuine OTA/DNA 
adducts in tumour tissue reflects their tumour-causing role for the mycotoxin, or shows an attractive 
proliferating depot in a morbid ageing subject where traces of circulating OTA can accumulate in 
malignant tumour. The evidence could just represent genetic damage that was unrepairable by 
malignant tumour. Study of tumours in non-urological tissues of BEN subjects could reveal data to 
clarify any specificity to urological tissue. In any case, in establishing an aetiological connection of 
OTA with all or part of the pathologies of BEN it would be vital to demonstrate consistent correlation 
of evidence of toxin exposure with disease development; correlation only in a proportion of cases 
would not suffice for satisfactory proof. 
Upper tract urothelial tumours [40] occurring in some BEN patients are all transitional cell 
neoplasms irrespective of their close proximity to the kidney in the renal pelvis. In contrast, the most 
potent expression of experimental renal cancer specifically by OTA is in the male rat, but tumours are 
all closely associated with the renal parenchyma and are found in ageing animals, even if OTA 
exposure occurs only during the first third of a normal lifespan. 
Extensive literature on analysis for OTA in food commodities and human diets, and also human 
blood, records the widespread occurrence of traces of the toxin, but no notable pattern of exceptional 
geographic foci [41,42]. However, a dietary study in 16 young healthy adults (gender not specified) in 
two Bulgarian hyperendemic villages found consistent exposure to OTA [43], but in two subjects the 
amounts were close to or slightly exceeded the current provisional tolerable weekly intake (100 ng/ kg 
body weight) recommended at that time by JECFA. By definition, this may not impose a health risk, 
but these individuals (if identified) may be particularly valuable for long-term assessment of OTA 
toxicology. However, another survey in the same region had found hardly different mean daily intake 
of OTA (1.21 µg and 1.03 µg, respectively) in BEN households versus households in non-BEN 
villages [44].  
Even the sources of the OTA detected in some BEN areas are still unclear. The dominant   
OTA-producing fungus in Northern Europe is P. verrucosum, and of more tropical areas is A. 
ochraceus and the black-spored species A. niger and A. carbonarius. Studies on food-borne moulds in 
the specific houses in the Croatian village of Kaniza [12] revealed none of the above. One isolate of P. 
variabile showed blue fluorescence in agar culture, but this was not due to OTA. A more detailed 
study in 20 BEN households across five Bulgarian hyperendemic villages [13] found one example of 
A. ochraceus, with a weak expression of OTA biosynthesis, and two atypical forms of P. verrucosum 
which did not produce OTA. However, two Penicillia (Figure 5) from maize, P. griseofulvum  Toxins 2010, 2               
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(IMI 351303) and an atypical P. viridicatum, produced OTA in laboratory culture on shredded wheat 
(1–2 ppb). Also, an isolate (Figure 5) assigned as another atypically-ochratoxinogenic species (P. 
solitum (IMI 351303), supported significant OTA productivity (1.3 ppm) in shredded wheat. These 
fungi had been isolated from the hyperendemic village of Gorno Peshtene, also included in the study 
by Vrabcheva et al. [43]. Subsequent study of low-grade local cereals, distant from the Bulgarian BEN 
endemic area and used for feed in pig production units where mycotoxic porcine nephropathy 
occurred, revealed no obvious ochratoxinogenic fungi [15]. Clearly there has been considerable under-
investment in understanding the mycological epidemiological aspect of putative mycotoxin 
involvement in BEN. 
Figure 5. Fungi isolated from maize (containing ochratoxin A) in a BEN household in 
Gorno Peshtene, Bulgaria cultured for taxonomic identification according to Pitt [45] on 
Czapek-yeast agar (left), G25N agar (centre) and malt extract agar (right) for 7 days at  
25 ºC. Within each plate: P. verucosum (left), P. griseofulvum (above), P. solitum (below), 
P. viridicatum (right). The latter three isolates were ochratoxinogenic [14]. 
 
4. Conclusions 
Potential for application of the present technique for DNA ploidy measurement in Balkan TCC, 
archived in wax blocks or preserved in formalin, has been demonstrated in this pilot study and could 
add valuable information on the contrasting extent of nuclear instability in primary TCC and RCC. 
However, further analysis would require a well-funded and dedicated programme. It should be 
remembered that the precise aetiological relationship between the silent bilateral renal atrophy of BEN 
and the upper urinary tract TCC that arise in some cases remains unclear. To define the extent of 
nuclear instability across the resource of tumours archived within the Balkan countries could add 
fundamental information to which mode(s) of mutagenic mechanism of putative toxicants (including 
OTA) in animal models might be compared for a possible fit. 
5. Experimental Section  
5.1. Ploidy analysis 
DNA ploidy distribution analysis was performed as previously described [22] and applied recently 
to rat renal tumours [21]. Briefly, several 50 µm sections were cut from selected areas of blocks, Toxins 2010, 2               
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dewaxed in xylene, rehydrated and nuclei extracted using protease type XXIV (Sigma Chemical Co., 
Poole, UK) [23].  Nuclear monolayers were prepared in a cytospin 4 (Thermo Shandon, UK) and 
stained by the Feulgen-Schiff method and analysed on a Fairfield image-based ploidy analyzer 
(Medical Solutions, UK). Monolayers were analysed using the automated scanning option. Diagnostic 
criteria for ploidy status were as previously published for this system. A sample was classified as 
diploid if only one G0/G1 (2c) peak was present, or if the number of nuclei in the G2 (4c) peak did not 
exceed 1% of the total number of epithelial cells. A lesion was defined as aneuploid if non-euploid 
peaks were present, or if the number of nuclei with DNA content greater than 5c exceeded 1%. 
5.2. Tissues relating to renal cell carcinoma 
Tumour details for Palle Krogh (Figure 6): In June 1988 (age 53) CT-scanning revealed an 8 cm 
tumour in the lower part of the right kidney. Needle aspiration showed cells suspicious of renal cell 
carcinoma (RCC). One month later, radical nephrectomy removed a carcinoma (9 × 8 × 8 cm) located 
at the lower pole. The cut surface had areas of necrosis and haemorrhage. The tumour did not 
obviously extend beyond the capsule, but did extend into the renal vein. A tumour thrombus   
(10 × 5 × 5 mm) was removed from the inferior vena cava. Microscopically, it was a typical RCC of 
clear cell type, moderately differentiated. Tumour tissue with similar morphology was found in the 
renal vein and in the inferior vena cava. The primary renal cell tumour at operation was staged as 
T3bN0M0. In September 1989 a solitary metastasis of a clear cell carcinoma was removed from soft 
tissue in the right femoral region. Notably, recent MRI illustration of a femoral metastatic deposit is 
shown in [24]. In February 1990 biopsies from the right main bronchus, lower right bronchus and at 
the bifurcation showed metastasis from RCC; histopathology was of the clear cell type. 
Figure 6. Prof. Palle Krogh (1935–1990). 
 
 
Control male: Currently resident in England, age 56 at radical left nephrectomy. The tumourous 
kidney (300 g) had a partially necrotic and haemorrhagic tumour at the upper pole of the kidney  
(11 × 9 × 6 cm). There were multiple external nodules (largest 1.5 cm in diameter) in perirenal fat. Toxins 2010, 2               
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Microscopically, the tumour was a moderately differentiated RCC with areas of haemorrhage and 
necrosis; the tumour infiltrated through the capsule into perirenal fat. Areas showed lymphovascular 
invasion, but renal vein and large arteries were free of tumour. Pathological grade was Fuhrman’s 
grade 2 and Robens stage at least 2. Additionally, bladder mucosa had a well-differentiated papilliary 
transitional cell carcinoma, pathological grade G1pTa.  
5.3. Romanian transitional cell tumours (TCC) from female BEN patients (2002–2004): 
Case 1; 75 years. Gross: Left kidney, tumour located in the renal hilum, 3 × 1.5 × 1.5 cm, exophytic 
aspect, friable. Microscopy: TCC, papillary, moderately differentiated G2. Chronic pyelonephritis in 
the adjacent parenchyma. Proximal ureter and bladder wall not affected. 
Case 2; 70 years. Gross: Dorso-lumbar wall tumour, infiltrating the fat, muscle and upper dermis,  
3 × 3.8 cm, solid, high consistency. Microscopy: TCC, moderately differentiated G2, associated to 
poorly differentiated adenocarcinoma.  
Case 3; 65 years. Gross: Left kidney, tumour of pelvic origin, 7 × 6.5 cm, papillary aspect, friable, 
necrotic-haemorrhagic. Microscopy: TCC, moderately/poorly differentiated G2/3, with foci of 
squamous differentiation, tumor necrosis, hyalinization, calcifications and vascular invasion. Chronic 
pyelonephritis in the adjacent parenchyma. No tumour invasion into proximal or distal ureter. 
Case 4; 74 years. Gross: Left kidney, tumour of pelvic origin, One dilated calyx containing   
a slightly raised tumour, 0.2 × 1 × 1.5 cm. Microscopy: TCC, poorly differentiated G3, infiltrating the 
submucosa. Chronic pyelonephritis in the adjacent parenchyma. Tumour invasion of ureter as small, 
multiple islands of the same cancer type, infiltrating the whole ureter wall. 
Control female: 69 years in 2001. Romanian benign papillomatous skin tumour, not associated  
with BEN 
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